Development and validation of RP HPLC method for the estimation of Sofosbuvir and related impurity in bulk and pharmaceutical dosage form
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2314-7253
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Development and validation of RP HPLC method for the estimation of Sofosbuvir and related impurity in bulk and pharmaceutical dosage form ; volume:7 ; number:1 ; day:28 ; month:7 ; year:2021 ; pages:1-10 ; date:12.2021
Future Journal of Pharmaceutical Sciences ; 7, Heft 1 (28.7.2021), 1-10, 12.2021
- Creator
-
Ganji, Shiny
Dhulipala, Satyavati
Nemala, Appala Raju
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43094-021-00285-5
- URN
-
urn:nbn:de:101:1-2021102501223504035570
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ganji, Shiny
- Dhulipala, Satyavati
- Nemala, Appala Raju
- SpringerLink (Online service)
Other Objects (12)
Impurity profiling method development and validation of metformin hydrochloride and teneligliptin hydrobromide hydrate in their combination tablet dosage form by using RP-HPLC with UV/PDA detector
Impurity Profiling of Baclofen Using Gradient HPLC–UV Method
Analytical method development and validation of hydrocortisone and clotrimazole in topical dosage form using RP-HPLC
BPS soliton-impurity models and supersymmetry
A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol
Simultaneous chromatographic analysis of Sofosbuvir/Ledipasvir in their combined dosage form: an application to green analytical chemistry
Development and validation of stability-indicating RP-HPLC method for estimation of dalfampridine in bulk drug and tablet dosage form
Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma
Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
A new validated stability-indicating RP-HPLC method for simultaneous quantification of dolutegravir and lamivudine in bulk and pharmaceutical dosage form
A new RP–HPLC method for simultaneous quantification of perindopril erbumine, indapamide, and amlodipine besylate in bulk and pharmaceutical dosage form
Menstruation and childbirth in the Bible : fertility and impurity
Impurity profiling method development and validation of metformin hydrochloride and teneligliptin hydrobromide hydrate in their combination tablet dosage form by using RP-HPLC with UV/PDA detector
Impurity Profiling of Baclofen Using Gradient HPLC–UV Method
Analytical method development and validation of hydrocortisone and clotrimazole in topical dosage form using RP-HPLC
BPS soliton-impurity models and supersymmetry
A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol
Simultaneous chromatographic analysis of Sofosbuvir/Ledipasvir in their combined dosage form: an application to green analytical chemistry
Development and validation of stability-indicating RP-HPLC method for estimation of dalfampridine in bulk drug and tablet dosage form
Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma
Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
A new validated stability-indicating RP-HPLC method for simultaneous quantification of dolutegravir and lamivudine in bulk and pharmaceutical dosage form
A new RP–HPLC method for simultaneous quantification of perindopril erbumine, indapamide, and amlodipine besylate in bulk and pharmaceutical dosage form
Menstruation and childbirth in the Bible : fertility and impurity
Impurity profiling method development and validation of metformin hydrochloride and teneligliptin hydrobromide hydrate in their combination tablet dosage form by using RP-HPLC with UV/PDA detector
Impurity Profiling of Baclofen Using Gradient HPLC–UV Method
Analytical method development and validation of hydrocortisone and clotrimazole in topical dosage form using RP-HPLC
BPS soliton-impurity models and supersymmetry
A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol
Simultaneous chromatographic analysis of Sofosbuvir/Ledipasvir in their combined dosage form: an application to green analytical chemistry
Development and validation of stability-indicating RP-HPLC method for estimation of dalfampridine in bulk drug and tablet dosage form
Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma
Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
A new validated stability-indicating RP-HPLC method for simultaneous quantification of dolutegravir and lamivudine in bulk and pharmaceutical dosage form
A new RP–HPLC method for simultaneous quantification of perindopril erbumine, indapamide, and amlodipine besylate in bulk and pharmaceutical dosage form